AtriCure, Inc. Files 8-K on Financials
Ticker: ATRC · Form: 8-K · Filed: Oct 29, 2024 · CIK: 1323885
Sentiment: neutral
Topics: regulatory-filing, financials
Related Tickers: ATRC
TL;DR
ATRC filed an 8-K on Oct 29th for financial updates.
AI Summary
AtriCure, Inc. filed an 8-K on October 29, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing is a standard regulatory disclosure for AtriCure, Inc., providing investors with updates on the company's financial performance and condition.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new material information that would inherently increase risk.
Key Players & Entities
- AtriCure, Inc. (company) — Registrant
- October 29, 2024 (date) — Date of Report
- 7555 Innovation Way, Mason OH 45040 (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the 8-K covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific figures within this excerpt.
When was this 8-K filing submitted?
The filing was submitted on October 29, 2024.
What is the principal business address of AtriCure, Inc.?
The principal executive offices are located at 7555 Innovation Way, Mason, OH 45040.
What is AtriCure, Inc.'s SIC code?
AtriCure, Inc.'s Standard Industrial Classification (SIC) code is 3841 for Surgical & Medical Instruments & Apparatus.
What is the SEC file number for AtriCure, Inc.?
The SEC file number for AtriCure, Inc. is 000-51470.
Filing Stats: 579 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2024-10-29 16:01:16
Filing Documents
- atrc-20241029.htm (8-K) — 28KB
- exhibit991-10292024.htm (EX-99.1) — 150KB
- image_0.jpg (GRAPHIC) — 3KB
- 0001323885-24-000115.txt ( ) — 314KB
- atrc-20241029.xsd (EX-101.SCH) — 2KB
- atrc-20241029_lab.xml (EX-101.LAB) — 21KB
- atrc-20241029_pre.xml (EX-101.PRE) — 12KB
- atrc-20241029_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 29, 2024 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2024. The Company will hold a conference call on October 29, 2024 at 4:30 p.m. Eastern Time to discuss the financial results. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in each of Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated October 29, 2024 relating to financial results for the third quarter ended September 30, 2024. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: October 29, 2024 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer